Siemens acquires Dotmatics

2025-04-02 · Publisher : Siemens · Domain : Industry 4.0 & 5.0

Siemens signs the acquisition of Dotmatics, a life sciences R&D software vendor, for $5.1 billion from Insight Partners. The deal extends its AI-powered PLM from research to pharmaceutical production; closed on 1 July 2025.

### Background On 2 April 2025, Siemens announces an agreement to acquire **Dotmatics**, a Boston-based life sciences R&D software vendor, for **$5.1 billion** from Insight Partners. Siemens thereby extends its product lifecycle management (PLM) offering to pharmaceutical and biotech research, linking the lab to manufacturing. Completion is announced on 1 July 2025. ### Key facts - Dotmatics offers a platform of scientific applications and multimodal data management for R&D. - Siemens estimates the deal expands its industrial software addressable market by **$11 billion** (vendor estimate). - Financing mainly through the sale of shares in listed companies, including Siemens Healthineers. - Integration into Siemens Xcelerator as part of the ONE Tech Company program. ### Why it matters The digital twin logic, born in automotive and aerospace, extends to drug discovery. For pharmaceutical manufacturers, data continuity between lab experiments, process development and production becomes a PLM vendor argument, not just one for lab specialists. ### Takeaway Siemens' second large software acquisition within days of closing Altair: the group speeds up its shift toward software.

Tags : Acquisition, PLM, Sciences de la vie, Siemens